Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -68.72% vs 2.09% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
YoY Growth in year ended Mar 2025 is -7.18% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is NA vs NA in Mar 2024
Compare Balance Sheet Results of Johnson Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
55.00
8.00
47.00
587.50%
Share Warrants & Outstandings
Total Reserve
1.17
41.03
-39.86
-97.15%
Shareholder's Funds
56.17
49.02
7.15
14.59%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.61
0.00
0.61
0.00%
Secured Loans
0.61
0.00
0.61
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
0.63
-0.63
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.61
0.63
-0.02
-3.17%
Current Liabilities
Trade Payables
0.00
5.12
-5.12
-100.00%
Other Current Liabilities
1.15
3.77
-2.62
-69.50%
Short Term Borrowings
0.00
1.27
-1.27
-100.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
1.15
10.16
-9.01
-88.68%
Total Liabilities
57.93
59.82
-1.89
-3.16%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
2.02
-2.02
-100.00%
Less: Accumulated Depreciation
0.00
0.66
-0.66
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
1.36
-1.36
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
42.29
41.10
1.19
2.90%
Long Term Loans & Advances
14.27
4.60
9.67
210.22%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
56.56
47.07
9.49
20.16%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
4.19
-4.19
-100.00%
Sundry Debtors
0.00
2.20
-2.20
-100.00%
Cash and Bank
0.01
0.28
-0.27
-96.43%
Other Current Assets
1.35
0.01
1.34
13,400.00%
Short Term Loans and Advances
0.00
6.07
-6.07
-100.00%
Total Current Assets
1.36
12.75
-11.39
-89.33%
Net Current Assets (Including Current Investments)
0.21
2.59
-2.38
-91.89%
Total Current Assets Excluding Current Investments
1.36
12.75
-11.39
-89.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
57.93
59.82
-1.89
-3.16%
Contingent Liabilities
0.00
1.14
-1.14
-100.00%
Total Debt
0.61
1.27
-0.66
-51.97%
Book Value per share (adjusted)
1.02
61.30
-60.28
-98.34%
Annual - Borrowings
Borrowings 0.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -68.72% vs 2.09% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
Investments 42.29 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.18% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 1.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is NA vs NA in Mar 2024
